Peripheral Neuropathy Treatment Market is Anticipated to Witness High Growth Owing to Rising Incidences of Neurological Disorders

Peripheral Neuropathy Treatment Market


 Peripheral neuropathy refers to damage or disease affecting any part of the peripheral nervous system. This includes nerve fibers or peripheral nerves located outside of the brain and spinal cord. Peripheral neuropathy causes numbness, pain, tingling and weakness usually in the hands and feet. The treatment market comprises drugs, therapies and medical devices used in the treatment of peripheral neuropathy conditions. Increasing prevalence of neurological disorders such as diabetes mellitus, chemotherapy-induced neuropathy andCharcot-Marie Tooth diseaseis driving demand for efficient treatment options.Lifestyle changes, genetic predisposition and environmental toxins are other major causative factors for peripheral neuropathy. Advancements in treatment technologies and rising awareness regarding management of neuropathic pain symptoms are boosting the global peripheral neuropathy treatment market.

The Global peripheral neuropathy treatment market Demand is estimated to be valued at US$ 2146.54 Bn in 2024 and is expected to exhibit a CAGR of 19% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the peripheral neuropathy treatment market are DMedHOK, Inc., Safecare Technology, Octal IT Solution, McKesson Corporation, LS Retail ehf., Liberty Software, Inc., GlobeMed Group, Datascan, Cerner Corporation, Allscripts Healthcare, LLC, and Epicor Software Corporation, among others.These players are focusing on developing innovative treatment solutions for efficient neuropathy pain management and improving quality of life.

The key opportunities in the market include rising adoption of minimally invasive procedures, increasing healthcare expenditures in emerging nations and growing demand for home healthcare services. Substantial investments in R&D of advanced therapeutics is also providing impetus to market growth.

Peripheral neuropathy treatment providers are expanding their global footprint to meet the rising needs of neurology patients worldwide. Favorable regulatory environment and healthcare reforms in various countries are encouraging international partnerships and collaborations for peripheral neuropathy management. The market is expected to witness high demand from Asia Pacific and Latin American countries over the forecast period attributed to rapid infrastructural development and increasing accessibility to modern treatment options.

Market Drivers
Increasing prevalence of diabetes is a major market driver. Per the International Diabetes Federation, over 537 million adults aged 20-79 years globally had diabetes in 2021 which is projected to rise to 643 million by 2030. Diabetes remains a leading cause of peripheral nerve damage. Moreover, rising geriatric population prone to age-related neuropathy and favorable reimbursement policies for neuropathic pain management are also fueling revenue growth of this market.

Market Restrains
High costs associated with advanced treatment devices and lack of effective therapy for chemotherapy-induced peripheral neuropathy poses a major challenge to market players. Limited awareness regarding benefits of early diagnosis and treatment among developing nations also restricts market expansion. Stringent regulations for new product approvals further delays market entry of novel therapies.


Segment Analysis
Peripheral neuropathy can be broadly classified based on cause as diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy and idiopathic peripheral neuropathy. Diabetic peripheral neuropathy dominates the market currently as it accounts for over 50% of the cases. High and rising global prevalence of diabetes is the key factor contributing to the large share of this segment. Within diabetic peripheral neuropathy, distal symmetric polyneuropathy is the most common type encountered in clinical practice.

Regional Analysis
North America currently dominates the peripheral neuropathy treatment market owing to high diagnosis and treatment rates in the region. Availability of advanced treatment options and high healthcare spending also support market growth in North America. Asia Pacific region is expected to grow at the fastest pace during the forecast period. Rising geriatric population, growing prevalence of diabetes and increasing awareness about neuropathic pain treatment in emerging economies of Asia Pacific are boosting the regional market. India and China are anticipated to witness highest growth within Asia Pacific peripheral neuropathy treatment market.

Get more insights on this topic: Peripheral Neuropathy Treatment Market

Comments

Post a Comment

Popular posts from this blog

The Notchback Market is Estimated To Witness High Growth Owing To Rising Demand From Emerging Economies

Image
  Notchback Market Market Overview: A notchback is a body style of cars characterized by a gently sloped rear window and greenhouse. Notchbacks provide practical interior space with good cargo capacity. They offer balanced interior volume for passengers and cargo along with sleek and stylish exterior design. The body style has advantages like no C-pillar which enhances visibility compared to sedans. Market key trends: The growth of the notchback market is attributed to rising demand from emerging economies like China, India and Brazil. These nations have growing middle-class population and increasing disposable income which is driving vehicle ownership. Moreover, notchback body style is quite popular in these developing markets due to its spacious cabin combined with stylish looks at affordable prices. Leading automakers are launching various notchback models to cater to the surging demand from developing countries, which is fueling the growth of the notchback market size during ...
Read more

The increasing demand for adhesives and sealants is anticipated to open up the new avenue for Petroleum Resins Market

Image
Petroleum Resins Market  Market Overview: Petroleum resins are amorphous thermoplastic polymers made from petroleum-based feedstock materials, through either thermal or catalytic polymerization. They are mainly used for applications such as adhesives, inks, paints, rubber compounding, and others. Different types of petroleum resins include C5 resins, C9 resins, hydrogenated hydrocarbons (HHCs), and modified and specialized petroleum resins. Among applications, adhesives and sealants hold the largest share in the petroleum resins market owing to increasing use of petroleum resins in hot melt and pressure sensitive adhesives. Market Dynamics: The increasing demand for adhesives from packaging and construction industries is a major driver for the petroleum resins market. According to statsista, the global adhesive market was valued at over US$ 53.3 billion in 2020 and is projected to reach around US$ 78 billion by 2027, growing at a CAGR of over 5.7% during the forecast period. Pe...
Read more

Global Synthetic Biology Market Analysis: Size and Share

Image
Synthetic Biology Market  Synthetic biology encompasses the design, construction, and redesigning of biological parts, devices, and systems, either non-existent in nature or reengineered from existing biological systems. The market is experiencing significant growth, driven by the increasing demand for personalized medicine and healthcare. Applications of synthetic biology span pharmaceuticals, chemical production, agriculture, environmental protection, and renewable energy. Advancements in synthetic biology contribute to the rapid manufacturing of biotherapeutics, fostering the development of personalized medicine and more cost-effective healthcare solutions. The Synthetic Biology Market is projected to be valued at US$ 31,693.59 million in 2023, with an expected CAGR of 28% during the forecast period from 2023 to 2030, according to a newly published report by Coherent Market Insights. Key Market Trends: A prominent trend in the Global Synthetic Biology Market is the escalat...
Read more